Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Intravenous (IV) Iron Drugs Market 2018: Oncology & Cardiology Segments are Witnessing Fastest Growth -

Research and Markets
Posted on: 14 Feb 18

The "Global Intravenous (IV) Iron Drugs Market: Analysis By Therapeutic Application, By Product Type, By Region, By Country (2018 Edition): Forecast to 2022" report has been added to's offering.

The global market is projected to display robust growth, represented by a CAGR of 11.19% by value during 2017 - 2022, chiefly driven by increase in healthcare spending and rising prevalence of diseases with Iron deficiency, emerging second & third generation IV Iron drugs and growing middle class income group coupled with rising health consciousness.

Over the recent years, the global Intravenous (IV) Iron Drug industry has been driven by the rising high prevalence of iron deficiency with unfulfilled needs, rising awareness, and the growing prevalence of diseases leading to severe iron deficiency and increasing healthcare expenditure in emerging economies. Globally, the growth in the IV Iron drug market is driven by the growing middle class population group, demanding better drugs to improve their lifestyle.

Among the therapeutic application type, nephrology accounts for the major market share and is anticipated to witness significant growth during the forecast period. Among the regions, the Asia-Pacific is predicted to advance at the highest rate, mainly driven by a large population suffering with iron deficiency and unfulfilled needs, improving access to healthcare, changing lifestyles, and an expanding middle class income group.

Scope of the Report

  • Global IV Iron Drug Market, By Value
  • By Therapeutic Application (Nephrology, Gynecology & Obstetrics, Gastroenterology, Oncology, Cardiology, Others); By Value
  • By Product Type (Ferric carboxymaltose, Iron Sucrose, Iron Dextran and Others), By Value

Key Topics Covered:

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. I.V. Iron Drug Market Outlook

5. Global I.V. Iron Drug Market: Growth and Forecast

6. North America I.V. Iron Drug Market: Growth and Forecast

7. Europe I.V. Iron Drug Market: Growth and Forecast

8. Asia Pacific I.V. Iron Drug Market: Growth and Forecast

9. ROW I.V. Iron Drug Market: Growth and Forecast

10. Market Dynamics

11. Market Restraints

12. SWOT Analysis - I.V. Iron Drug Market

13. Porter's Five Forces Analysis - I.V. Iron Drug Market

14. Policy and Regulations

15. Company Profiles

  • AMAG Pharmaceuticals Inc
  • Allergan PLC
  • Daiichi Sankyo Company Limited
  • Galenica
  • Nippon Shinyaku CO. LTD
  • Pharmacosmos A/S
  • Sanofi

For more information about this report visit

View source version on

Business Wire

Last updated on: 14/02/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.